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Kaposi’s sarcoma-associated herpesvirus (KSHV) establishes sustained latent persistence in susceptible cells. This is dependent
on the latency-associated nuclear antigen (LANA). Understanding how LANA transcription is regulated thus aids our funda-
mental understanding of KSHV biology. Two hundred ninety-four base pairs are sufficient to regulate LANA transcription in
response to the viral RTA protein and RBPj. The same region controls K14/viral G-protein-coupled receptor (vGPCR) tran-
scription in the opposite direction. We used a quantitative analysis in conjunction with specific nucleotide substitutions and
defined gain-of-function and loss-of-function RTA mutants to dissect this region. We used a bidirectional reporter driving red
and green luciferase to study the LANApi and K14p promoters simultaneously. This established that LANApi/K14p functions as
a canonical bidirectional promoter. Both were TATA dependent. K14p was favored by 50-fold in this context. Eliminating the
distal LANApi TATA box increased maximal output and lowered the induction threshold (T) of K14p even further. Two RBPj
binding sites were independently required; however, at high concentrations of RTA, direct interactions with an RTA-responsive
element (RRE) could complement the loss of one RBPj binding site. Intracellular Notch (ICN) was no longer able to activate
RBPj in the viral context. This suggests a model whereby KSHV alters ICN-RBPj gene regulation. When the architecture of
this pair of head-to-head RBPj binding sites is changed, the sites now respond exclusively to the viral transactivator RTA and
no longer to the host mediator ICN.
Kaposi’s sarcoma-associated herpesvirus (KSHV) is a humanoncogenic gammaherpesvirus. The KSHV genome is 137,000
bp long and encodes more than 70 open reading frames (ORFs).
KSHV is associated with Kaposi’s sarcoma (KS), primary effusion
lymphoma (PEL), and multicentric Castleman’s disease (MCD).
Viral transcription is tightly regulated and can be divided into two
well-defined states (22, 31). (i) During the lytic phase, the genome
replicates and every viral promoter is active. (ii) During latency,
the viral genome persists within the nucleus as a circular plasmid
(episome) and is subject to the same regulation as human chro-
mosomes (27, 66, 79). As a result, this minichromosome is tran-
scriptionally silent, with the exception of some key genes: the
KSHV latency locus and a few genes that respond to cell-type-
specific and environmental stimuli. The KSHV latency locus en-
codes vital viral genes, which drive latent episome persistence: for
instance, the latency-associated nuclear antigen (LANA) gene, as
well as all viral microRNAs (8, 21, 24, 37, 67, 78, 82). Latent genes
are central to KSHV tumorigenesis, since abrogation of LANA
protein expression by small interfering RNA (siRNA) results in
a loss of the KSHV plasmid and induction of apoptosis (26).
Conversely, LANA expression can drive B cell hyperplasia in
vivo (23, 72).
LANA, vCyc, vFLIP, the viral microRNAs (miRNAs), and ka-
posin are transcribed via alternative splicing from a single pro-
moter. Other promoters can regulate kaposin, vCyc/vFLIP, and
the microRNAs separately from LANA (4, 5, 8, 21, 48, 67, 71, 78).
The LANA promoter ensures the coordinated expression of this
KSHV latent gene cluster, including all viral microRNA. Elucidat-
ing the molecular details of this regulation can be expected to
contribute significantly to our understanding of KSHV persis-
tence and the AIDS-defining malignancies, KS and PEL. A contig-
uous 1,200-bp fragment contains all cis regulatory elements to
ensure constitutive LANA promoter (LANApc) activity (21, 32–
34). The LANA promoter is never methylated and is free of repres-
sive histone marks (16, 27, 79). Thus, this locus provides the op-
portunity to investigate general principles of promoter structure
and function in a defined genomic context; however, the situation
is more complicated.
During latency, LANApc, a largely constitutive promoter,
drives transcription of the LANA mRNA (Fig. 1A). It initiates
transcription at position 127880. It is B cell specific in transgenic
mice (33) and constitutively active in a large number of tissue
culture cell lines. During reactivation, additional promoters are
used. These are termed the LANApi, which is a promoter that can
drive LANA transcription in response to the viral immediate-early
transactivator RTA, and K14p, which is a promoter that drives a
large K14/viral G-protein-coupled receptor (vGPCR) mRNA.
Transcripts initiating from these two promoters have thus far
been detected only in lytically reactivating cells. Nested within the
LANApc untranslated region (UTR) is the bidirectional LANApi/
K14p promoter (Fig. 1A), which is the subject of this study. The
LANApi/K14 promoter is small (297 bp), and both transcription
start sites (TSSs) are inactive during latency despite being located
Received 14 April 2012 Accepted 21 June 2012
Published ahead of print 27 June 2012
Address correspondence to Dirk P. Dittmer, ddittmer@med.unc.edu.
Supplemental material for this article may be found at http://jvi.asm.org/.
Copyright © 2012, American Society for Microbiology. All Rights Reserved.
doi:10.1128/JVI.00881-12
September 2012 Volume 86 Number 18 Journal of Virology p. 9683–9695 jvi.asm.org 9683
within an open chromatin environment. The LANApi/K14p re-
gion is part of a large class of bidirectional regulatory regions.
Approximately 10% of human open reading frames (ORFs) are
regulated via bidirectional promoters (50, 80, 81). Bidirectional
promoters regulate two ORFs positioned 5= to 5= (“head to head”)
on opposite DNA strands. The TSSs for the majority of these bi-
directional promoters are separated by less than 400 bp. Members
of bidirectional gene pairs tend to utilize shared cis regulatory
elements. Another human gammaherpesvirus, Epstein-Barr virus
(EBV), also exploits this mode of regulation (35).
A number of studies have looked at either K14p or LANApi by
itself (46, 52, 57, 75) but thus far not at both in the bidirectional
context. The LANApi TSS is positioned 313 bp upstream of the
LANA protein translation initiation site (57, 75), and the K14p
TSS initiates transcription 35 bp upstream of the K14 translation
initiation site on the opposite strand (18, 41, 60). The LANApi TSS
utilizes a canonical TATA element (57, 75). A K14p TATA ele-
ment has been predicted but not yet confirmed by functional
studies. In sum, features of the LANApi/K14p pair resemble the
architectural (spacing and strand identity) and functional (coex-
pression and coregulation) features of bidirectional promoters.
The LANApi and K14p TSSs are induced by the KSHV RTA
transactivator. In fact, K14p is the most highly RTA-induced TSS
in the entire KSHV genome (20). The RTA-mediated transactiva-
tion of LANApi and K14p displays a strict reliance upon two bind-
ing sites (Fig. 1B) for the human transcriptional adaptor RBPj
(52, 57). The RTA-RBPj complex binds to these sites and acti-
vates the TSS. RTA functions as a multimer (6, 65). The situation
is more complex, however, since RTA can also bind DNA directly
through a loosely defined RTA-responsive element (RRE) (17, 73,
74) and thus can activate other viral promoters independent of
RBPj. Further, RBPj can be activated by its host partner intra-
cellular Notch (ICN) independent of any viral proteins (reviewed
in reference 58). The LANApi/K14p region contains two RBPj
elements, as well as a centrally located RRE, which could function
to regulate K14p, LANApi, or both.
To further understand this regulation, we applied a quantita-
tive model combined with single nucleotide and single amino acid
mutant alleles of the cis recognition sequence elements and the
RTA DNA binding domain. Transactivators (trans inputs) and
their cognate sequence elements (cis inputs) coalesce to regulate
mRNA production in the form of a transcriptional regulatory cir-
cuit (40). These regulatory circuits can be described in quantita-
tive terms using the Hill function (see equation 1) (39, 40, 44, 69).
This equation relates promoter output to transactivator concen-
tration. Traditional, enzymatic studies use purified proteins and
enzyme activity relates to the enzyme protein concentration. In
our transfection studies, we did not know the intracellular RTA
concentration, but we established that within the boundaries of
our transfection series, doubling the input of a transfected ex-
pression plasmid resulted in a linear increase in the RTA pro-
tein. Hence, we can use this equation to characterize promoter
behavior.
Three parameters describe the Hill function: the maximal out-
put, measured herein as RLU s1max; T, the induction threshold;
and n, the Hill coefficient, which is a measure of cooperativity. By
determining these parameters, we can make inferences about reg-
ulation and the biochemical mechanism of action.
RLU s1obs 




This mathematical framework is well known and has also been
applied to study promoter activity in transfected cells (39, 40, 44,
69). For instance, the induction threshold T determines at which
activator concentration the promoter is 50% active. A promoter
with a lower T will be more active at lower transactivator concen-
trations. The Hill coefficient, n, indicates the cooperativity of the
response. A Hill coefficient of 1 indicates a high degree of coop-
erativity and a step-like, “all-or-nothing” response curve; a Hill
coefficient of 1 indicates a more gradual response. The maximal
FIG 1 KSHV genomic organization of the LANApi and K14p TSSs. (A) Sche-
matic depiction of the nucleotide positions (according to reference 70) span-
ning the LANA and K14 coding regions within the KSHV latency locus (vCy-
clin, vFLIP, and vGPCR are omitted for simplicity); SD, splice donor site; SA,
splice acceptor site. LANApi, LANApc, and K14p TSSs as previously identified
are shown. Also shown are CTCF binding sites as previously identified (76).
(B) Sequence of the cloned genomic fragment used in analyses. Regulatory
elements are indicated by text and boxed. Mutated nucleotides described in
this report are shown in lowercase text, and nucleotide positions are indicated
in the key below. Horizontal triangles indicate relative RBPj directionality;
REV, location of the internal reversion mutant.
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output provides a measure of promoter strength. A weak pro-
moter will produce fewer transcripts (specifically, initiation events
per unit time) than a strong promoter. One way to understand
maximal output is as follows: at the limit, the promoter initiates as
many new transcripts per time unit as possible. Adding more spe-
cific transactivator no longer increases this rate, which is deter-
mined by how fast the general transcription factor complex can
assemble and “reset” at the TATA element.
Using this framework, we investigated the LANApi/K14p re-
sponse to RTA and report two new findings. (i) Our studies re-
vealed a competitive relationship between the two TSSs, i.e., we
found that one function of the LANApi TSS is to dampen the K14p
response to RTA. (ii) Since LANApi/K14p contains two RBPj
sites, we expected RTA-dependent transactivation to be highly
cooperative. This was not the case. We found an unconventional
utilization of the head-to-head RBPj element pair reminiscent of
sequence-paired site (SPS) Notch signaling (1, 10, 63) but evolved
to respond solely to the viral transactivator and no longer to ICN.
MATERIALS AND METHODS
Plasmids. All plasmids were sequence verified and match nucleotide po-
sitions 127583 to 128879 of the BC-1 KSHV genome (70). Site-directed
mutations are shown in Fig. 1B. LANApi and K14p single reporter con-
structs (pDD2002 and pDD2005, respectively) were generated by cloning
the genomic portion indicated above from pDD919 (nucleotides [nt]
127583 to 127879 in pBluescript II(KS) [Stratagene]) into pCBG68 Ba-
sic and pCBR Basic (Promega Corp.) via SmaI/HindIII and KpnI/SmaI
restriction sites, respectively. The bidirectional reporter construct
(pDD2000) was generated by cloning the green luciferase isoform
(pCBG68 Basic) into pDD919 via HindIII/SalI restriction sites, with a
secondary subcloning step to incorporate the red luciferase isoform
(pCBR Basic) via ligation of blunt-ended (End-It DNA repair kit; Epicen-
tre), SmaI/BamHI-digested pCBR Basic, with the SmaI-digested, green-
only vector intermediate. The LANApi single reporter, K14p single re-
porter, and bidirectional reporter variants, LANApiTBP (pDD2026,
-2027, and -2029_3-1), RBP A (pDD2024, -2028, and -2031), RBP B
(pDD2022, -2023, and -2030), and K14pTBP mutants (pDD2013, -2015,
and -2016), respectively, were generated using the GeneTailor site-di-
rected mutagenesis system (Invitrogen) and the GeneAmp high-fidelity
PCR system (Applied Biosystems). The bidirectional mutant variants,
RRE (pDD2038) and 611-843 REV (pDD2034), were designed as syn-
thetic oligonucleotides (Blue Heron Biotechnology Inc.) with flanking
HindIII sites for subcloning into the HindIII self-ligated bidirectional
empty vector (pDD2045). Regulatory elements were identified using the
software program Alibaba 2.1 and a literature review. The wild-type (WT)
ORF50 expression vector was a kind gift from J. Choe (28). 4X-RBPj Luc
(4X-CBF Luc) was generously provided by S. D. Hayward (30). The
ORF50 mutant expression vectors (ORF50 KK/EE and ORF50 R161A)
were generous gifts from G. Miller (13, 15). The Flag-tagged human in-
tracellular Notch- and Myc-tagged RTA (61)-encoding constructs were
kindly provided by J. Jung. Myc-tagged ORF50 KK/EE (pDD2032) and
ORF50 R161A (pDD2033) were generated using the same methods as in
reference 34.
Tissue culture and transfection. SLK cells (29) were cultured in Dul-
becco’s modified Eagle’s medium (DMEM) supplemented with 5% fetal
bovine serum, penicillin (0.05 g/ml), and streptomycin (5 U/ml) (Invit-
rogen Inc.) at 37°C under 5% CO2. SLK cells were seeded at a density of
1.0  104 cells per well in 96-well plates (Sarstedt). The next day, trans-
fection mixes were prepared using the RoboGo liquid handling system
(Aviso) (or by hand in the case of Fig. 8 only) and then mixed with in-
complete medium (DMEM without serum or antibiotic) and Superfect
(Qiagen) as per the manufacturer’s instructions. Total DNA was normal-
ized with pBluescript II(KS) (pDD223) such that a total 0.5 g of total
input DNA was transfected per well in all experiments. Similar to previous
observations (75), coincident expression of ORF50 consistently led to
deviations in the expression of -galactosidase, rendering this value un-
reliable for normalization purposes. We therefore relied on extensive bi-
ological replicates. Transfections utilized the MWG RoboGo liquid han-
dling system and were performed in triplicate, at least three different
times. Those transfections that were performed by hand were performed
in duplicate, at least two different times.
Luciferase data acquisition. Cells were lysed with 100 l 1 cell Cul-
ture lysis reagent (Promega), undergoing gentle orbital rotation for 10
min at room temperature. Lysate was then mixed with the Chromaglo
luciferase assay system (Promega) substrate or with luciferase assay sys-
tem (Promega) substrate as per the manufacturer’s instructions. Lucifer-
ase activity was measured using a FLUOstar Optima 96-well luminometer
(BMG Labtech). Red and green signal outputs were separated as per the
manufacturer’s instructions using a 590-nm long-pass and 510/60-nm
filter (Chroma Corp.), respectively. Luciferase activity was measured from
each well for 10 s at 1-s intervals, with the final values derived by the
luminometer software as the average of all interval readings (n 	 10), such
that the output therein was expressed as relative light units observed per
second (RLU s1obs). Filter correction was achieved using the Chroma-
Luc technology calculator (Promega).
Data fitting and analysis. Raw luciferase data in the form of RLU
s1obs was generated via titration of WT RTA, KKEE RTA, or R161A RTA,
with input values of RTA-encoding expression vector ranging from 0 to
86.5, 0 to 76.9, and 0 to 76.9 nM, respectively. Because equal molecular
weights were input to maintain the optimal 0.5-g/well transfection con-
ditions outlined above in all experiments, the different molecular
amounts between the input RTA expression vectors are reflective of the
differences in double-stranded molecular weights. The raw output curves
were fit to the Hill function (see equation 1) via nonlinear least-squares
regression (38), with three freely varying parameters: RLU s1max, T (ex-
pressed in nM), and n (the Hill coefficient). Independent regression anal-
yses were performed on each individual titration curve to generate inde-
pendent values of RLU s1max, T, and n for each individual trial (i.e., n 
9 data points per titration curve). Global values were subsequently calcu-
lated by fitting the averaged outputs across all runs from each condition to
generate a global fit, with standard error derived from the variance among
individual runs. Initial analyses revealed adherence to first-order Hill ki-
netics (see Fig. S1 in the supplemental material); as such, we fixed the Hill
coefficient to n 	 1 for subsequent calculations (see equation 2) (19, 39,
64). The apparent kcat and efficiency T were calculated as described above
(see equations 3 and 4). The initial concentration (Et) used to calculate the
apparent kcat was defined as the concentration (in nM) of measurable
input reporter construct (held constant throughout each titration curve).
This definition expresses the observed output as a function of total detect-
able molecular quantities, and other definitions (such as potential binding
sites, etc.) arbitrarily dilute this relationship. Due to the differences in
molecular weight, the single reporter alone, bidirectional reporter, and
single reporter in trans (1:1) thus had corresponding values of Et of 138
nM, 99 nM, and 69 nM, respectively.
Immunoblotting. SLK cells were transfected with Myc-tagged WT
RTA, Myc-tagged KKEE RTA, Myc-tagged R161A RTA, or Flag-tagged
ICN expression vectors as described above. After 4°C 1 phosphate-buff-
ered saline (PBS) rinsing, two of three wells were harvested, rinsed again,
and pooled, with subsequent lysis via RIPA buffer (50 mM Tris-HCl [pH
8.0], 150 mM NaCl, 1% NP-40, 0.5% deoxycholate [DOC], 0.1% SDS, 1
mM NaVO3, 1 mM dithiothreitol [DTT], 1 protease inhibitor cocktail
[Sigma], and 1 mM phenylmethylsulfonyl fluoride [PMSF]). Total pro-
tein from lysates was normalized via a bovine serum albumin (BSA) assay
(Pierce) and separated on 10% SDS-PAGE followed by transfer to PVDF
membrane (GE Healthcare). Membranes were blocked in 5% nonfat milk
in PBST (0.1% Tween 20). Antibodies were diluted in blocking buffer at
1:1,000 for anti-Myc (Cell Signaling), 1:5,000 for anti-Flag (Sigma),
1:5,000 for anti--actin (Sigma), and 1:5,000 for anti-mouse horseradish
peroxidase (HRP) (Vector Labs). Luciferase analysis was carried out on
LANA Promoter
September 2012 Volume 86 Number 18 jvi.asm.org 9685
the remaining wells to ensure that epitope-tagged RTA variants re-
sponded similarly to responses of untagged variants (data not shown).
RESULTS
LANApi and K14p form a bidirectional promoter. To under-
stand LANApi and K14p, we cloned the KSHV genomic region
encompassing both TSSs (nt 127583 to 127879 [70]) into a dual
reporter context (Fig. 2A). The LANApi TSS drove a green-emit-
ting luciferase isoform and the K14p TSS drove a red-emitting
luciferase isoform on the same plasmid. Previous experiments by
us and others (46, 52, 57, 75) always used either one or the other
promoter but never investigated both TSSs within the same con-
struct.
We transfected the bidirectional-reporter vector and single-
reporter controls with increasing amounts of an RTA transactiva-
tor expression construct into SLK cells. SLK cells are derived from
a KS lesion but do not carry KSHV (29). As a control, we switched
the isoforms in some experiments and obtained the same response
curves (data not shown). We used 12 different amounts of RTA
expression plasmid to obtain high-resolution response curves.
Western blotting confirmed expression of RTA upon transfection
(Fig. 2D).
RLU s1obs 
(RLU s1max) · [RTA]
[RTA]  (T)
(2)
To test the hypothesis that RTA cooperatively transactivates
either TSS, the response (RLU s1obs) to increasing amounts of
input RTA-encoding expression vector was fit to the Hill function.
We found no evidence of cooperativity (i.e., Hill coefficient  1;
see Fig. S1 in the supplemental material). This was surprising for a
transactivator like RTA, which functions as a dimer or tetramer.
The RTA response curves exhibited first-order kinetics. These can
be modeled by the simpler equation 2 (19, 64). It suggests that the
RTA transactivation complex does not assemble from individual
monomers cooperatively at the DNA interface but that the slowest
and thus rate-determining step is RTA dimerization/tetrameriza-
tion. Our data suggest that in intact cells, RTA dimerization/te-
tramerization happens prior to DNA binding.
Bidirectional promoter is dominated by K14p. Both TSSs
were responsive to RTA when transfected as single reporters (Fig.
2B and C, triangles) or when positioned in the bidirectional ori-
entation (Fig. 2B and C, circles). Regardless of context, however,
the K14p TSS had 10- to 100-fold-higher maximal output than the
LANApi TSS. K14p was a much stronger promoter.
FIG 2 LANApi and K14p are bidirectional promoters activation by RTA. (A) Single and bidirectional reporter constructs. LANApi directs expression of a green
luciferase isoform, and K14p directs expression of an isogenic red luciferase isoform. (B) The response to RTA for LANApi in single (triangles) and bidirectional
(circles) reporter input contexts. (C) The K14p response to RTA in single (triangles) and bidirectional (circles) reporter input contexts. (D) RTA expression over
the range of input expression vector as assayed by Western blotting. (E) Induction threshold 
 SE for each TSS.
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Since these experiments were conducted in transfected cells
rather than with purified components in vitro, they take into ac-
count all molecular interactions that lead to luciferase output.
Thus, rather than absolute numbers, the relative comparison of
LANApi and K14p is important. We assume that the only variable
in our experiments is the amount of RTA, and we conducted a
series of validation experiments to support our data (see Fig. S2 in
the supplemental material). Each data point is the result of three
technical replicates. Each titration experiment was conducted in at
least three biological replicates on different days. We switched the
colored luciferase isoforms to verify that the response curves were
defined by the cis elements rather than the reporter. We conducted
real-time quantitative PCR (qPCR) for each luciferase reporter
mRNA to show that the level of luciferase activity was linearly
correlated with the level of mRNA and that the amount of trans-
fected reporter DNA was the same among all replicates (see Fig. S2
in the supplemental material). These experiments validated that
the luciferase readings are an accurate reflection of TSS activity.
Because the RTA response could be described by a first-order
kinetic fit, we were able to calculate the parameters which charac-








kcat describes the promoter behavior at saturating levels of a
specific transactivator. A higher kcat value indicates more tran-
scription initiation events per unit time. In kinetic studies, it re-
lates the maximal output to the enzyme concentration (Et). Here,
calculating an apparent kcat allowed us to directly compare exper-
iments that used the bidirectional promoter and experiments that
used the single reporter (as well as mutants) and also to normalize
across biological replicates that transfect different amounts of lu-
ciferase reporter constructs.
K14p had a kcat value of 713 
 64 RLU s
1, and LANApi had a
kcat value of 175 
 32 RLU s
1 (Fig. 3A), verifying the differential
promoter strength we observed when analyzing the raw data in
each individual experiment.
LANApi TATA element limits K14p activity. We observed a
consistent increase in the induction threshold T (Fig. 2E) for both
TSSs when assayed in the bidirectional context compared to re-
sults in the single-reporter context. For K14p, the induction
threshold T shifted from 4.2 nM input vector DNA for the single
reporter to 13.1 nM in the bidirectional-reporter context. For
LANApi, the induction threshold T shifted from 7.4 nM for the
single-reporter to 33.7 nM in the bidirectional-reporter context.
A second, very informative and perhaps more relevant param-
eter (2, 25) is the ratio of kcat to T (see equation 4). This ratio is the
promoter efficiency. It can be thought of as promoter activity at
physiological levels, i.e., at and around the induction threshold T
(the analog to T in enzyme biochemistry is the Km, though that
strictly applies only to purified proteins). It is the most biologically
relevant comparator among promoters. A promoter can be very
strong (high kcat), but if the induction threshold T is high, it will
yield little output at low concentrations of transactivator. Con-
versely, a promoter can be very sensitive, i.e., become active at very
low concentrations of transactivator, and still not yield much out-








For each LANApi and K14p, the efficiency was much lower in
the bidirectional context than in the single-reporter context
(Fig. 3B, compare filled bars to empty bars). This reduction in
efficiency when assayed in the bidirectional promoter construct
compared to the single-reporter context was statistically signifi-
cant, with a P value of 0.005 for LANApi and a P value of 0.05
for K14p using Student’s t test. Similar differences were observed
regardless of the luciferase isoform assayed (data not shown).
These results provided the first indication that in the bidirectional
context, more RTA is required for induction than in the single-
reporter context. One model to explain this difference proposes
that both TSSs compete for a central common RTA binding site.
In the single-reporter context, the distal TSS is not functional.
Even though a preinitiation complex may assemble, there is no
ORF to transcribe and no poly(A) site to support efficient tran-
scription. In the bidirectional reporter, preinitiation complexes
assemble around both TATA elements and now can compete for
the arriving RTA complex. This model predicts that the distal
TATA element negatively regulates promoter activity, i.e., the
LANApi TATA would inhibit K14p and vice versa (Fig. 4A).
To test this hypothesis, we inactivated the predicted TATA
elements through site-directed mutagenesis. LANApi activity was
dependent on a proximal TATA element. If we mutated the prox-
imal LANApi TATA element, activity was abolished (Fig. 4B, ar-
row and red triangles). K14p activity also was dependent upon the
proximal TATA element (Fig. 4C, gray diamonds). Note that pan-
FIG 3 RTA transactivation based on fit to noncooperative response model
(Hill constant 	 1). (A) The maximal output is shown for each TSS when
assayed as single reporters alone (black bars) or in the bidirectional reporter
(white bars). (B) The efficiency of RTA-mediated induction is shown for each
TSS as single reporters (black bars) or in the bidirectional reporter (white
bars). “” indicates P  0.05; “” indicates P  0.01. P values were deter-
mined by Student’s t test.
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els B and C have different scales to account for the different overall
activities. These experiments confirm the LANApi TATA element
and define the K14p TATA element, which had been predicted but
was not previously experimentally verified.
Deletion of the distal, (LANApi) TATA element dramati-
cally increased the activity of K14p (Fig. 4C, red triangles and
arrow). This observation is consistent with the aforementioned
model in which the distal LANApi element inhibits K14p in the
context of the bidirectional promoter. By comparison, deletion
of the distal (K14p) TATA element only marginally affected
LANApi activity (Fig. 4B, gray diamonds). This observation
introduces asymmetry into the model. The LANApi TATA el-
ement inhibits the K14p TSS, but the K14p TATA element has
no impact on the LANApi TSS. In the absence of the LANApi
TATA element, the K14p promoter became hyperresponsive to
RTA. This prompted us to hypothesize that a second purpose of
LANApi was the inhibition of K14p, more than driving the
expression of the LANA protein.
FIG 5 Both RBPj elements are essential. (A) Schematic depicting the position of the LANApi- and K14p-proximal RBPj elements (RBP A [circle] and RBP B
[square], respectively) mutated for analysis in the bidirectional reporter construct. (B) LANApi response to RTA in the presence (WT; crosses) or absence of
TSS-proximal (RBP A; circles) or TSS-distal (RBP B; squares) RBPj elements. (C) K14p response to WT RTA in the presence (WT; Xs) or absence of
TSS-proximal (RBP B; squares) or TSS-distal (RBP A; circles) elements. Note the change in scale between panels 5B and C.
FIG 4 The LANApi-proximal TATA box binding protein (LANApi TATA) element limits K14p output. (A) Schematic illustrating the positions of the LANApi
and K14p-proximal TATA elements (LANApi TATA [triangle] and K14pTATA [diamond], respectively) that were mutated in the bidirectional reporter
construct. (B) LANApi response to RTA in the presence (WT; cross) or absence of TSS-proximal (LANApi TATA; triangles) or TSS-distal (K14p TATA;
diamonds) elements. (C) K14p response to WT RTA in the presence (WT, X’s) or absence of TSS-proximal (K14p TATA; diamonds) or TSS-distal (LANApi
TATA; triangles) elements. Note the 10-fold change in scale between panel B and panel C.
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Direct DNA binding by RTA augments promoter efficiency.
Binding of RTA to the bidirectional LANApi/K14p region is me-
diated by RBPj, which is the essential downstream mediator of
Notch signaling (reviewed in reference 42). Two RBPj elements,
RBP A and RBP B, mediate the response to RTA (Fig. 5A) (52, 57).
To verify these observations, we mutated each in the context of the
bidirectional reporter construct. As predicted, mutation of either
RBPj element abolished promoter activity (Fig. 5B and C; please
note the 10-fold difference in scale between the two panels). This
demonstrates that both RBP elements were necessary.
In addition to RBPj-mediated DNA recognition, RTA can
also bind DNA directly (9, 15, 51, 65, 68). To test the hypothesis
that direct RTA-DNA interactions were important, we used an
RTA mutant with enhanced DNA binding capacity, called KKEE
(13, 15). KKEE RTA increased the activity for both LANApi and
K14p TSSs in the context of the bidirectional reporter. The max-
imal output increased from the WT level of 17,000 to 130,000
RLU s1 for the LANApi promoter and from the WT RTA level of
70,000 to 880,000 RLU s1 for the K14p. This translated into
an increase in kcat of 7.3-fold for LANApi and 12.4-fold for K14p.
In contrast, another mutant, RTA R161A, which is capable of
interaction with RBPj (12) but no longer binds DNA directly,
decreased the efficiency for each TSS compared to results with
wild-type RTA (Fig. 6A and D). This demonstrated that in addi-
tion to binding via RBPj, RTA binds directly to a binding site
within K14p/LANApi and that this RTA-DNA interaction modu-
lates the activation efficiency of either TSS.
To test the hypothesis that the KKEE mutant phenotype was
dependent on an intact promoter, we analyzed TSS efficiency for
the TATA box mutants. Enhanced DNA binding by RTA could
not compensate for a mutated proximal TATA box, presumably
because there was no RNA polymerase II (Pol II) complex to ac-
tivate in the first place. We recorded only a minimal signal (Fig. 6B
and F). The DNA binding mutant RTA R161A was worse than the
wild type under all conditions tested. As before, we observed an
increase in K14p efficiency if the distal TATA box was compro-
FIG 6 Enhanced DNA binding by RTA augments promoter activity. (A) Log LANApi efficiency in response to increased RTA DNA binding (KKEE RTA) or loss
of RTA DNA binding (R161A RTA). (B and C) Efficiency of the LANApi response to KKEE, WT, or R161A RTA in the absence of proximal LANApi TATA (B)
or distal K14p TATA (C). Note that in the absence of the proximal TATA element (B), we did not see significant reporter activity. (D) K14p efficiency in response
to increased RTA DNA binding (KKEE RTA) or loss of RTA DNA binding (R161A RTA). (E and F) Efficiency of the K14p response to KKEE, WT, or R161A RTA
in the absence of distal LANApi TATA (E) or proximal K14p TATA (F). Note that in the absence of the proximal TATA element (F), we did not see significant
reporter activity. , P  0.05;  P  0.01; , P  0.001; P values were determined by Student’s t test, and dotted lines indicate mean WT efficiency.
LANA Promoter
September 2012 Volume 86 Number 18 jvi.asm.org 9689
mised (Fig. 6D and E). This was not the case for LANApi (Fig. 6A
and C). More subtle differences were also evident. In the wild-type
situation, the KKEE mutant enhanced efficiency (Fig. 6A and D);
however, in the context of a mutated distal TATA element (Fig. 6E
and C), this was no longer the case. In sum, the hypermorphic
phenotype of the KKEE mutant can be attributed solely to in-
creased DNA binding. The dependency on the general transcrip-
tion complex remains.
To test the hypothesis that at saturating concentrations RTA
no longer depends on its own DNA binding activity, we used the
R161A mutant, which is deficient in binding to the RTA-respon-
sive element (RRE) but still binds to RBPj. First, we analyzed
RTA R161A in the context of the wild-type promoter. There was
no significant difference between the WT and the R161A mutant
(Fig. 7A, and D, yellow bars). As expected, the KKEE mutant had
increased activity (Fig. 7A and D, blue bars). The maximal output
was 26,458 
 3,993 RLU s1 for the R161 mutant, compared to
17,275 
 3,181 RLU s1 for the WT RTA for LANApi and
80,527 
 9,735 RLU s1 for the R161 mutant for K14p, compared
to 70,439 
 6,347 RLU s1 for the WT RTA for K14p. Thus, direct
RTA-DNA interactions are not required at saturating concentra-
tions of RTA. All contacts are established through RBPJ.
What would happen in the absence of an RBPj binding ele-
ment? Inactivation of either RBP A or RBP B severely reduces the
activation by RTA. This was the main message of the results shown
in Fig. 5. However, the power of our quantitative analysis and the
large number of replicates and dose steps allows us to compare
accurate parameters, such as maximal output, shown in Fig. 7,
among promoters of vastly different activities. At saturating con-
centrations, the DNA binding mutant R161 was no worse than the
wild type on the LANApi promoter. (Fig. 7B and C, yellow). The
situation was different for K14p (Fig. 7E and F, yellow). In the ab-
sence of a functional RBP A site, R161A RTA had a lower maximal
output than the WT on K14p (Fig. 7E, red star). In the absence of
FIG 7 At saturating levels, RTA DNA binding becomes dispensable. (A) Normalized LANApi maximal output (analogous to kcat for enzymes) in response to
increased RTA DNA binding (KKEE RTA) or loss of RTA DNA binding (R161A RTA) mutant. (B and C) LANApi response in the absence of proximal RBP A
(B) or distal RBP B (C). (D) Normalized K14p maximal output in response to increased RTA DNA binding (KKEE RTA) or loss of RTA DNA binding (R161A
RTA). (E and F) K14p response to KKEE, WT, or R161A RTA in the absence of distal RBP A (E) or proximal RBP B (F). The red star indicates a significant (P 
0.05) difference between WT and R161A RTA only in K14p with a mutated RBP A element (E). , P  0.05; , P  0.01; ***, P  0.005; , P  0.001. P values
were determined by Student’s t test; dotted lines indicate the mean WT promoter response to WT RTA.
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a functional RBP B site, which is proximal to K14p, the R161A
DNA binding mutant was identical to the wild type. This suggests
that the RRE contributes to the activity of K14p. Note that loss of
any one RBP site severely cripples the promoter. Hence, this dif-
ference should not be overinterpreted.
In each case the KKEE mutant could substitute for the loss of
an RBP site (Fig. 7, blue bars). In the context of a wild-type pro-
moter, KKEE RTA was better than WT RTA, as previously ob-
served. In the context of an RBP-deficient promoter, KKEE RTA
was able to complement the cis defect and restore kcat to wild-type
levels. These data demonstrate that improved interactions be-
tween RTA and an RRE DNA element in the case of KKEE RTA
can complement for a loss of interaction between RTA-RBPj and
a single RBP site.
The absence of functional DNA binding by RTA increased the
activation threshold for both TSSs. The induction threshold was
126.4 
 2.7 nM for the R161 expression plasmid, compared to
33.7 
 8.3 nM for the WT for the LANApi TSS, and 80 
 14.2 nM
for the R161 mutant, compared to 13.1 
 5.5 nM for the WT for
the K14p TSS. Of note, R161 also makes normal RBPj interac-
tions. This verifies two aspects of our model: (i) direct RTA-DNA
contacts increase the responsiveness of these TSSs at low concen-
trations of RTA, and (ii) at saturating concentrations, the direct
RTA-DNA contacts can complement RBPj element defects.
The direct RTA-DNA contact is mediated by a regulatory ele-
ment, termed the RTA Response Element (RRE), which is present
between the two RBP elements (Fig. 8A). Previously this RRE
element was shown to have less of an impact upon transactivation
than the RBPj elements (52, 57). We confirmed these observa-
tions. Loss of the RRE site led to equivalent reductions in output
for both TSSs when assayed with any RTA variant (data not
shown). This suggests that three cis elements, RBP A, RBP B, and
RRE, together define the response behavior of the K14/LANApi
bidirectional promoter.
Sequence architecture between TBP elements provided di-
rectionality for RBPj transactivation. Since RTA binding sites
function in tandem, transactivation could in principle act toward
either side. In isolation, RTA-RBPj can bind to and activate pro-
moters independent of orientation (51). In contrast, we hypothe-
sized that spacing of the RBPj elements imparted directionality
to the bidirectional KSHV promoter. To test this hypothesis, we
switched the orientation of the intervening sequence between the
two TATA elements (Fig. 8A). We then cotransfected either the
WT or KEEE RTA at a 1:1 molar ratio. Reversing the sequence
of binding sites relative to LANApi increased the output of
LANApi (Fig. 8B). This was true for either mutant. KKEE RTA
in this experiment served as a better RTA. The reverse was not
true. Reversing the sequence of binding sites relative to K14p
did not increase the output of K14p (Fig. 8C). This demon-
strates that the specific orientation and distance of the two
RBPj binding sites and the RRE element confer preferential
activation of the K14p TSS.
RBPj binding sites are RTA specific and insensitive to
Notch. Given the stringent reliance of this viral promoter upon
the effector of Notch signaling, RBPj, we hypothesized that over-
expression of the host ligand might also activate these TSSs. The
host ligand for RBPj is the transcriptionally active, cleaved form
of the human Notch protein: intracellular Notch (ICN). Unlike
RTA, ICN does not have RBPj-independent DNA binding activ-
ity and thus cannot engage the RRE. We transfected cells with
LANApi, K14p, or a positive control consisting of 4 RBPj sites.
The positive control containing four RBPj sites (31) responded
as expected (Fig. 9A); however, neither K14p nor LANApi re-
sponded to activation by ICN. Western blotting confirmed ICN
expression (Fig. 9B). Thus, even though the RBPj elements are
essential with regard to RTA-mediated induction of either TSS,
their orientation within the viral promoter can no longer use ICN.
We had observed a similar phenotype when we profiled KSHV
gene expression in response to ICN and RTA (11). One possibility
to explain this phenotype comes from recent observations that
revealed a requirement for ICN target loci to have a head-to-head,
paired RBP element orientation as well as strict spacing require-
ments (26–28). In human promoters the canonical architecture is
spatially restricted to a maximum distance of 15 to 19 bp be-
tween adjacent RBPj sites. In contrast, 79 base pairs bridge the
two head-to-head RBPj sites in the KSHV promoter (Fig. 9C). By
extending the sequence spacing, the RBPj pair can no longer be
bridged by ICN but requires multimers of a different transactiva-
tor: RTA.
FIG 8 Directionality of RTA-RBPj transactivation. (A) Depiction of the REV
mutant (sequence reversal of 2 bp relative to TATA elements) in the bidi-
rectional reporter. RRE refers to the predicted RTA direct DNA binding ele-
ment. (B) LANApi output in the WT (black bars) and REV (white bars) bidi-
rectional promoter variants in response to KKEE or WT RTA. (C) K14p
output in the WT (black bars) and REV (white bars) bidirectional promoter
variants in response to KKEE or WT RTA.). , P  0.01; P values were
determined by Student’s t test.
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DISCUSSION
The KSHV latency control region plays multiple roles during the
viral life cycle. During de novo infection, the immediate-early
transactivator RTA is brought in with the virion (3, 46). This re-
sults in an initial burst of lytic and latent transcription (43). Dur-
ing this phase, RTA drives LANA and K14/vGPCR protein expres-
sion from the lytic LANApi and K14/vGPCR promoters (54).
Eventually the constitutive LANA promoter takes over. It is active
independent of RTA or other viral proteins (33, 34). As LANA
protein accumulates, it also inhibits RTA (36, 45). This leads to a
stable autoregulatory loop during which LANA activates its own
promoter (32, 34). Reexpression of RTA is necessary and suffi-
cient for KSHV reactivation (55, 56, 77, 84). Yet LANA is dispens-
able for KSHV reactivation and replication in KSHV and related
gammaherpesviruses (7, 49, 53, 59, 83). Perhaps LANApi evolved
not to regulate LANA protein expression during lytic replication.
Perhaps the unique architecture of two divergent RTA-dependent
TSSs in such close proximity reveals a novel molecular mechanism
of RTA/RBPj/ICN regulation. To investigate these conjectures,
we studied the regulation of LANApi and of K14p in quantitative
terms.
This report demonstrates that the LANApi/K14p locus consti-
tutes a bona fide KSHV bidirectional promoter. This is the first
functional verification of a bidirectional promoter within the
KSHV genome; others are predicted (I. B. Hilton, D. Wang, and
D. P. Dittmer, unpublished). Bidirectional transcription has been
identified in Epstein-Barr-Virus (EBV) (35, 47). It was studied in
yeast and other eukaryotic model systems (62). By applying the
same quantitative framework to KSHV, we have generated a de-
tailed understanding of the functional roles that cis (regulatory
elements) and trans (DNA binding) factors play in the transacti-
vation of this genetic circuit. Each TSS (LANApi, K14p) is respon-
sive to RTA when positioned on the same reporter. At least three
shared RTA-responsive elements (RBP A, RBP B, and RRE) mod-
ulate this response. There exists a selective advantage for the K14p
TSS. K14p is 10 to 100 more active than LANApi.
This report demonstrates a competitive relationship between
the two TATA elements. This is reflected in a decreased efficiency
for each TSS in the bidirectional reporter relative to the single-
reporter-only input condition. The distal LANApi TATA element
negatively regulates and limits K14p. A similar phenotype has
been seen for some bidirectional promoters in yeast (62). Here
too, mutation of one TATA element resulted in upregulation of
the other. In the majority of those cases, however, the second distal
TATA box initiates a noncoding or “cryptic” transcript. In the case
of KSHV LANApi, the resulting transcript has the potential to
encode the entire LANA ORF. We speculate that perhaps the
LANApi TATA box evolved for two purposes: first, to drive tran-
scription of the LANA protein during lytic replication, but more
importantly to fine-tune the expression of K14 and vGPCR.
The interaction between RTA and RBPj is well established
(12, 46, 51, 52, 54, 57, 65, 68, 75). Biochemical evidence suggests
that RTA functions as a tetramer. This higher-order RTA complex
then stabilizes RBPj on the DNA and changes conformation such
that the transactivation event takes place (6, 9, 14, 65). Here we
have shown that while both RBP elements are critical, their im-
portance is differential. The RBP B element is located 71 bp from
the K14p TATA element (Fig. 10). The RBP A element is located
only 7 bp from the LANApi TATA element. This introduces asym-
metry. The asymmetry is also reflected in the spacing between the
RRE and the RBPj elements. The RRE is spaced 17 bp away from
the K14p-proximal RBP B element. This is the same spacing as for
ICN-dependent RBPj pairs. In contrast, the RRE is spaced 50 bp
away from the LANApi-proximal RBP A element. The net result is
FIG 9 Response to intracellular Notch (ICN). (A) Fold change in relative luciferase activity in response to ICN for each TSS in the bidirectional reporter
(LANApi, circles; K14p, triangles) or the TSS of positive control 4X-RBPj Luc (diamonds). (B) Expression of ICN, detected by Western blotting. (C) Illustration
of the unequal RBPj head-to-head spacing within the LANApi/K14p bidirectional promoter. Shown are the distances in bp between the two RBP elements (top)
and between each RBP element and the central RRE. Also shown are the two essential TATA elements for each promoter.
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that K14p is 10 to 15 times more active at physiological, low con-
centrations of RTA. Last, we show that ICN no longer activates
these paired RBP sites, because of extended spacing, and that now
RTA is required as the bridging factor.
Taken together, we suggest the following model (Fig. 10).
Based on prior work on RBPj (58), we assume that in the ground
state RBPj exists as a transcriptional repressor of both the
LANApi and K14p TSSs (Fig. 10A). RBPj bound to RBP A effec-
tively occludes other molecules from binding the LANApi TATA
element due to extreme proximity (7 bp). In contrast, 71 base
pairs separate the RBP B element from the K14p TATA element.
Thus, the repression mediated by RBP B is less potent, resulting in
a preassembly of the basal machinery at the K14p TSS. The RTA
complex (likely tetrameric) then interfaces with the RBPj-bound
DNA using the RRE to position the higher-order complex in favor
of RBP B (Fig. 10B). Only 17 bp separates RRE from RBP B, com-
pared to 50 bp which separates RRE from RBP A. This asymmetric
assembly leads to an approximately 10-fold advantage for the
K14p TSS over LANApi (Fig. 10C).
Since both LANA and vGPCR mediate important phenotypes
in KSHV persistence, transmission, and tumorigenesis, the de-
tailed dissection of this regulatory unit may contribute to our
overall understanding of KSHV biology and gene regulation.
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